Search Immortality Topics:

Page 8,524«..1020..8,5238,5248,5258,526..8,5308,540..»

12th National Conference: Parkinson's 2010: Recent clinical advances in the management of Parkinson's (Jun 23, 2010, London, United Kingdom, Europe)

Posted: May 23, 2010 at 8:17 am

Cliquez pour écouter ce texte The British Journal of Hospital Medicine in conjunction with the Parkinson's Disease Society is delighted to announce its 12th National Parkinson's Conference. Parkinson's 2010 is aimed at all health and social care professionals involved in the clinical management of people with Parkinson's. It will be an educational event providing a state-of-the art update on the current clinical developments taking place in the field.
Participants will benefit from receiving:

  • A comprehensive overview of the current and future pharmacotherapies in use.
  • A greater understanding of the management of non- motor symptoms including sleep disorders, impulse control disorders, visual dysfunction and Parkinson's dementia.
  • A raised awareness of the indications for deep brain stimulation.
  • An insight into end of life care for people with Parkinson's.
  • Information from leading experts in the field on the optimal management strategies in use today. We would be delighted if you could join us for what promises to be an exciting and informative day.
  • Please do book early to be sure of your place.
  • Recommendation and review posted by Fredricko

    Metabolic pathway plays a role in susceptibility to stuttering

    Posted: May 23, 2010 at 8:16 am

    Stuttering is a disorder of unknown cause characterized by repetitions, prolongations, and interruptions in the flow of speech. Genetic factors have been implicated in this disorder, and previous studies of stuttering have identified linkage to markers on chromosome 12.

    This study shows that variants of proteins that guide hydrolases to the lysosome are associated with stuttering. This unexpected finding implies a metabolic pathway in susceptibility to stuttering.

    Video: Biology Homework about Lysosomes.


    Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.

    Recommendation and review posted by G. Smith

    Health benefits of chocolate

    Posted: May 23, 2010 at 8:16 am

    The health benefits of chocolate may include:

    - Reduction of blood pressure by eating 6 grams of dark chocolate per day. Probably due to the flavonol epicatechin
    - Reduction of platelet and endothelial cell activation
    - Reduction of inflammatory mediators
    - It can also inhibit oral caries
    - It can cross the blood brain barrier and increase cerebral blood flow in humans

    From Writer's Almanac:

    Ode to Chocolate by Barbara Crooker (excerpt)

    I hate milk chocolate, don't want clouds
    of cream diluting the dark night sky,
    don't want pralines or raisins, rubble
    in this smooth plateau. I like my coffee
    black, my beer from Germany, wine
    from Burgundy, the darker, the better.

    The Essence of Chocolate. Dr Shock MD PhD, 2010.

    Image source: Wikipedia, public domain.

    Posted at Clinical Cases and Images. Stay updated and subscribe, follow us on Twitter and connect on Facebook.

    Recommendation and review posted by G. Smith

    "Many Dead Things: The Specimens of Alex CF," Superette Gallery, London

    Posted: May 23, 2010 at 8:16 am

    Friend-of-Morbid-Anatomy Suzanne G. of the incomparable Wurzeltod website and Tumblr, asked me to help get the word out about the upcoming exhibition: "Many Dead Things: The Specimens of Alex CF." The opening reception will take place on May 17th and the show will be on view until June 12th.

    Full information following; check it out!

    27 May – 2 June 2010
    Opening reception: 27 May, 6 – 9 PM | 28 May – 2 June, 12 – 6 PM daily

    Superette Gallery
    66A Sclater Street, Off Brick Lane
    London, E1 6HR, United Kingdom

    In his first solo exhibition, following the release of his monograph, artist Alex CF offers the public a unique opportunity to see his bizarre specimens in person – objects that have so far only been witnessed by private collectors, such as Maxime Chattam (author) or Reece Shearsmith (actor, League of Gentlemen) who wrote the foreword for his book, and will be lending pieces from his own collection for the show.

    Alex has spent the last five years crafting wondrous relics of an alternate past – a rich tapestry of 19th century cryptozoological artifacts and creatures that challenge our understanding of the natural world: The mummified remains of a vampire child, the taxidermied corpse of a 7-foot-tall adult werewolf, the trappings of scientists and archaeologists pertaining to the study of these species in the form of antique research cases, amongst many other fascinating objects.

    The show will encompass a number of works including 6 new pieces and Alex will be signing his book.

    Alex’s work has been featured in a number of well-known publications both online and in print, such as Weird Tales, Bizarre, BoingBoing, and io9. His work has also been featured on book covers, and in a number of independent films.

    Click here to download press release.

    To find out more, visit the exhibition website by clicking here. To visit Suzanne's amazing Wurzeltod website, click here; to visit her equally if not more amazing Tumblr, click here.

    Image: By Alex CF, from exhibition website: L’enfant Diabolique, mixed media, 2010

    Recommendation and review posted by G. Smith

    Thomas Goetz has the wrong debate. FDA doesn’t intend to restrict.

    Posted: May 23, 2010 at 8:15 am

    I think everyone in this space has been way off base as to what the problem is with FDA and Congress wanting to investigate the DTC Genomics companies.

    The whole mindset is wrong.

    What I hear from this debate is "It's my data, mine, mine, mine. Gimmee, Gimmee, you can't keep me from my data Big Brother!"

    From Mr Goetz's Blog
    "The controversy seems to have stirred the FDA to assert its authority – and that of physicians – over any and all medical metrics."

    "To me, getting access to this information is a civil rights issue. It’s our data."

    This is a straw man argument that has been set up to make regulating these companies seem unseemly and an invasion of privacy.

    IT IS A DEAD WRONG ARGUMENT and I will not stand for it being perpetuated anymore.

    This is not about getting access to your data.

    Fine, you want a whole genome, go get it!

    The FDA is not asking should people be able to go out and buy this. It is asking several other questions.

    1. Is Interpretation of biometric data considered medicine?
    The answer here is certainly confusing. I think it rests solely with intent.

    Do you intend to tell someone something about a disease they now have based on this biometric data that you analyzed?

    If the answer is yes, that is viewed legally and medically as a diagnosis.
    Which ultimately I think is medicine and falls under medical regulations.

    2. Is DTCG analyzing biometric data and intending to give an interpretation of that data which indicates a disease a person has?

    It depends on what you define disease as.

    Most legal experts defer to the International Classification of Diseases

    3. Should we regulate a system which has not given indication of their quality control if they are indeed intending to provide medical diagnosis?

    4. Are these methods of obtaining human samples to derive biometric data for the intent of analyzing and providing information about disease considered medical devices?

    This is precisely the argument and precisely what Congress and the FDA are trying to define.

    So stop acting like a bunch of little kids running around because someone took your kool aid away!

    If I hear another, "It's my data" whine again I will scream.

    This is not about restricting access to biometric data.

    Which by the way, some states do already.

    Is an EKG biometric data? What about a cholesterol?

    Probably, no one is stopping you from going out and buying a machine to obtain this data yourself.

    But any doctor will tell you, it is the interpretation that can vary widely. As demonstrated by the multiple interpretations that Venter complained about

    What they are intending to do is to prevent a third party from having NO ONE to answer to when providing interpretation of that very SAME biometric data.

    The Sherpa Says: Regulation here will most definitely not stifle innovation as bad as a consumer death or class action lawsuit or lack of trust from consumers because of the aforementioned.

    Recommendation and review posted by G. Smith

    Natural compounds in carnivorous plants could fight human fungal infections

    Posted: May 23, 2010 at 4:09 am

    The vast array of plants in nature includes carnivorous plants that kill to survive. How can a plant zap a flying or crawling insect? By using a highly evolved group of compounds and secondary metabolites to trap and absorb prey. Now Tel Aviv University researchers say they've found a way these natural plant compounds could benefit human health by fighting serious fungal infections.

    The Venus fly trap is probably the best known example of a carnivorous plant. Native to the tropics, these plants lure unsuspecting beetles, ants, flies and other creatures into a cavity filled with liquid that botanists call a "pitcher". The instant insects fall into this trap, enzymes are activated that dissolve the bugs and provide the plant with needed nutrients, such as carbon and nitrogen, which can be difficult to extract from soil. Read more...

    AyurGold for Healthy Blood

    Recommendation and review posted by G. Smith

    Page 8,524«..1020..8,5238,5248,5258,526..8,5308,540..»